sq-11725 has been researched along with albuterol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Lipworth, BJ; McDevitt, DG; McFarlane, LC; Wheeldon, NM | 1 |
| Lipworth, BJ; McDevitt, DG; Wheeldon, NM | 2 |
| Kalish, R; Kydonieus, A; Wille, JJ; Wood, JA | 1 |
| Azevedo, ER; Newton, GE; Parker, JD | 1 |
| Horinouchi, T; Koike, K | 1 |
| Montpetit, CJ; Perry, SF | 1 |
| Bond, RA; Dickey, BF; Franklin, AE; Garner, WJ; Hanania, NA; Lipworth, BJ; Mannava, B; Williamson, PA | 1 |
1 review(s) available for sq-11725 and albuterol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
3 trial(s) available for sq-11725 and albuterol
| Article | Year |
|---|---|
Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Basal Metabolism; Bisoprolol; Blood Glucose; Fatty Acids, Nonesterified; Glycerol; Humans; Insulin; Lactates; Lactic Acid; Male; Nadolol; Phenethylamines; Potassium; Single-Blind Method | 1994 |
Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Bisoprolol; Drug Interactions; Hemodynamics; Humans; Male; Myocardial Contraction; Nadolol; Phenethylamines; Tremor | 1994 |
The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Albuterol; Cross-Over Studies; Dose-Response Relationship, Drug; Exercise; Female; Humans; Hyperkalemia; Male; Nadolol; Single-Blind Method; Tachycardia; Tremor | 1994 |
14 other study(ies) available for sq-11725 and albuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Sensitization of mice to topically applied drugs: albuterol, chlorpheniramine, clonidine and nadolol.
Topics: Administration, Cutaneous; Albuterol; Animals; Anti-Asthmatic Agents; Antihypertensive Agents; Biological Availability; Chlorpheniramine; Clonidine; Dermatitis, Allergic Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Eruptions; Female; Histamine Agonists; Linear Models; Mice; Mice, Inbred CBA; Nadolol; Skin Absorption; Vitamin A | 1996 |
Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Atenolol; Cardiac Catheterization; Chest Pain; Coronary Disease; Coronary Vessels; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Contraction; Nadolol; Norepinephrine; Sympathetic Nervous System; Sympathomimetics | 1999 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Adrenergic regulation of catecholamine secretion from trout (Oncorhynchus mykiss) chromaffin cells.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Albuterol; Analysis of Variance; Angiotensin II; Animals; Carbachol; Catecholamines; Chromaffin Cells; Clonidine; Dobutamine; Electric Stimulation; Epinephrine; Female; Male; Nadolol; Norepinephrine; Oncorhynchus mykiss; Perfusion; Phentolamine; Phenylephrine; Receptors, Cholinergic; Vasoactive Intestinal Peptide | 2002 |
Response to salbutamol in patients with mild asthma treated with nadolol.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Asthma; Female; Humans; Male; Middle Aged; Nadolol; Propranolol; Respiratory Function Tests; Treatment Outcome | 2010 |